The effect of a comprehensive, mail-based motivational program for patients receiving lipid-lowering therapy.
The effects of a mail-based compliance program for patients receiving lipid-lowering therapy were assessed in a retrospective, observational study. During the first year of the "Close to the Heart" program, 79% of 3,077 previously noncompliant patients filed claims for statin medications, resulting in increased percentages of patients who reached optimal or near-optimal serum lipid goals. Among patients who restarted therapy, approximately 72% were more than 70% compliant. This comprehensive compliance program administered by a large insurance company appears to have helped patients restart and maintain statin therapy, resulting in improved serum lipid profiles and reduced risk of cardiovascular complications.
Truppo
Colleen
C
Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ), Newark, New Jersey, USA.
Keller
Vivian A
VA
Reusch
Maria Teresa
MT
Pandya
Bhavik
B
Bendich
David
D
D000293:Adolescent; D000328:Adult; D000368:Aged; D054598:Blue Cross Blue Shield Insurance Plans / Q000458:organization & administration; D008078:Cholesterol, LDL / Q000097:blood; D019468:Disease Management; D004345:Drug Industry / Q000458:organization & administration*; D011307:Drug Prescriptions / Q000191:economics; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D007373:Interinstitutional Relations; D008297:Male; D008329:Managed Care Programs / Q000458:organization & administration*; D008875:Middle Aged; D009042:Motivation; D009515:New Jersey; D009519:New York City; D010349:Patient Compliance / Q000523:psychology / Q000706:statistics & numerical data*; D010353:Patient Education as Topic / Q000379:methods*; D015397:Program Evaluation
D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors